Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 infection: the OzCombo 2 study
Martyn French*, Janaki Amin, Norman Roth, Andrew Carr, Matthew Law, Sean Emery, Fraser Drummond, David Cooper
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
51
Link opens in a new tab
Citations
(Scopus)